OVERVIEW

Exploring the Role of JAK Inhibitors Across the Spectrum of IMIDs is organized by Healthcare Made Practical (HMP) Communications LLC and will be held from Jun 29, 2018 - Jun 29, 2019.

Intended Learners:
This activity is designed for dermatologists, rheumatologists, gastroenterologists, immunologists, nurse practitioners, nurses, physician assistants, pharmacists and other healthcare professionals involved in the management of patients with autoimmune diseases.

Accreditation:
0.75 CME
0.75 CNE
0.75 CPE

Course Overview:
This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Learning Objectives:
After completing this activity, participants should be able to:

• Examine the reasons why the mechanism of action of JAK inhibitors leads to efficacy across diverse disease states
• Review efficacy data on currently approved JAK inhibitors
• Summarize trial data on emerging applications for JAK inhibitors
• Review safety data and adverse events associated with this class of small molecule therapeutics

Additional details will be posted as soon as they are available.